<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Rhophylac; Anti-D (Rh0) immunoglobulin; Immunoglobulins: anti-D (Rh0)" /><meta name="IX" content="Rhophylac; Anti-D (Rh0) immunoglobulin; Immunoglobulins: anti-D (Rh0)" /><title>Rhophylac®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="106248.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="106248.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=106248.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2081.htm">14 Immunological products and vaccines</a> &gt; <a href="6538.htm">14.5 Immunoglobulins</a> &gt; <a href="202723.htm">14.5.3 Anti-D (Rh<sub>0</sub>) immunoglobulin</a> &gt; <a href="202726.htm">ANTI-D (Rh0) IMMUNOGLOBULIN</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="202723.htm" title="Previous: 14.5.3 Anti-D (Rh0) immunoglobulin">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="6558.htm" title="Next: 14.6 International travel">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>British National Formulary (3)</h3></li><li><a href="202723.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">14.5.3 Anti-D (Rh0) immunoglobulin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.5 Immunoglobulins</p></div></li><li><a href="202726.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ANTI-D (Rh0) IMMUNOGLOBULIN</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.5 Immunoglobulins &gt; 14.5.3 Anti-D (Rh0) immunoglobulin</p></div></li><li><a href="6553.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Anti-D (Rh0) Immunoglobulin</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 14 Immunological products and vaccines &gt; 14.5 Immunoglobulins &gt; 14.5.3 Anti-D (Rh0) immunoglobulin &gt; ANTI-D (Rh0) IMMUNOGLOBULIN</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/999901-n3575-v.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Human Anti-D Immunoglobulin Ph E.ur (Pharmacopoeial)</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Preparations &gt; By country &gt; Pharmacopoeial &gt; H</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_202726">ANTI-D (Rh<sub>0</sub>) IMMUNOGLOBULIN</h1><div id="pC" class="jN"><div class="cAF"><h2>Indications</h2> <p class="cAF">see notes above</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">immunoglobulin A deficiency; possible interference with live virus vaccines, see under <a title="BNF:target-block: Normal immunoglobulin notes" href="202710.htm#_202708">Normal Immunoglobulins</a>, section 14.5.1,
but see <a title="target-block: MMR vaccine note in Anti-D" href="202723.htm#_202724">notes above</a> about
administration with MMR vaccine</p></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">treatment of idiopathic thrombocytopenia
purpura in rhesus negative or splenectomised patients</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">nausea, vomiting, diarrhoea, abdominal pain; hypotension,
hypertension, headache, fever, malaise, asthenia, drowsiness, dizziness,
back pain, arthralgia, myalgia; pruritus, rash, sweating, injection
site pain; <i>rarely</i> tachycardia, anaphylaxis, dyspnoea,
hypotension, and urticaria; (for side-effects associated with <i>intravenous</i> immunoglobulins, see <a title="BNF:sub-section: Normal immunoglobulin" href="202710.htm#_202710">section 14.5.1</a></p></div><div class="cAF"><h2>Dose</h2> <p class="cR">See preparations below</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="6553.htm#_6553" title="Anti-D (Rh0) Immunoglobulin">Anti-D (Rh<sub>0</sub>) Immunoglobulin</a></li><li class="jN" id="_106248" style="margin: 0 0 0 20px;"><h1 class="title">Rhophylac®<span> (<a href="appendix-112803-C.htm#m738">CSL Behring</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Injection</span>, anti-D (Rh<sub>0</sub>) immunoglobulin 750 units/mL (150 micrograms/mL), net price 2-mL
(1500-unit) prefilled syringe = £46.50.<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF"><span class="cU">by intramuscular</span><i> or </i><span class="cU">intravenous injection</span>, to rhesus-negative woman for prevention
of Rh<sub>0</sub>(D) sensitisation:</p></div><div class="cAF"><p class="cAF">Following birth of rhesus-positive infant, 1000–1500 units
immediately or within 72 hours; for large transplacental bleed, extra
100 units per mL fetal red cells (preferably by intravenous injection) </p></div><div class="cAF"><p class="cAF">Following any potentially sensitising episode (e.g. abortion,
amniocentesis, chorionic villous sampling) up to 12 weeks’ gestation
1000 units per episode (after 12 weeks, higher doses may be required)
immediately or within 72 hours</p></div><div class="cAF"><p class="cAF">Antenatal prophylaxis, 1500 units given between weeks
28–30 of pregnancy; if infant rhesus-positive, a further dose is still
needed immediately or within 72 hours of delivery</p></div><div class="cAF"><p class="cAF">Following Rh<sub>0</sub>(D) incompatible blood transfusion, <span class="cU">by intravenous injection</span>, 50 units per mL transfused rhesus-positive
blood (or 100 units per mL of erythrocyte concentrate)</p><div class="cAR cAU"><h3>Note</h3> <p class="cAX">Intravenous route recommended for patients
with bleeding disorders. </p></div></div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="202723.htm">Previous: 14.5.3 Anti-D (Rh<sub>0</sub>) immunoglobulin</a> | <a class="top" href="106248.htm#">Top</a> | <a accesskey="]" href="6558.htm">Next: 14.6 International travel</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>